Journal
METABOLITES
Volume 13, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/metabo13101087
Keywords
gender; sex; metabolic syndrome; diabetes; hypercholesterolaemia; arterial hypertension; cardiovascular diseases; heart failure
Categories
Ask authors/readers for more resources
This review examines the impact of gender on medication adherence in metabolic and cardiovascular diseases. The study finds that in type 2 diabetes, female sex, younger age, new drug prescription, non-white ethnicity, low education level, and low income are predictors of non-adherence. Women with hypercholesterolemia exhibit poorer adherence to statin therapy. Adherence to anti-hypertensive therapy shows conflicting results. Limited evidence suggests that women may have poorer adherence after acute myocardial infarction and stroke.
This review explores the impact of gender on medication adherence in the context of metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for achieving treatment goals and preventing adverse outcomes in chronic diseases. The review examines specific conditions such as type 2 diabetes, hypercholesterolemia, arterial hypertension, cardiovascular diseases, and heart failure. In type 2 diabetes, female sex, younger age, new drug prescription, non-white ethnicity, low education level, and low income were identified as predictors of non-adherence. Depressive disorders were also found to influence adherence. In hypercholesterolemia, women exhibited poorer adherence to statin therapy compared to men, with statin-related side effects and patient perception being significant factors. Adherence to anti-hypertensive therapy showed conflicting results, with studies reporting both higher and lower adherence in women. Limited evidence suggests that women may have poorer adherence after acute myocardial infarction and stroke. Regarding heart failure, adherence studies have shown inconsistent findings. The reasons for gender differences in medication adherence are multifactorial and include sociodemographic, disease-related, treatment-related, and psychological factors. This review emphasizes the need for further research to better understand these differences and develop gender-customized interventions that can improve medication adherence and reduce the burden of metabolic and cardiovascular diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available